z-logo
open-access-imgOpen Access
Neuron‐oligodendrocyte myelination co‐culture derived from embryonic rat spinal cord and cerebral cortex
Author(s) -
Pang Yi,
Zheng Baoying,
Kimberly Simpson L.,
Cai Zhengwei,
Rhodes Philip G.,
Lin Rick C. S.
Publication year - 2012
Publication title -
brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.915
H-Index - 41
ISSN - 2162-3279
DOI - 10.1002/brb3.33
Subject(s) - oligodendrocyte , neuroscience , spinal cord , myelin , biology , myelin basic protein , embryonic stem cell , cerebral cortex , neuron , cytoarchitecture , central nervous system , neural stem cell , microbiology and biotechnology , stem cell , biochemistry , gene
An in vitro myelination model derived from rat central nervous system (CNS) remains to be established. Here, we describe a simple and reproducible myelination culture method using dissociated neuron‐oligodendrocyte (OL) co‐cultures from either the embryonic day 16 (E16) rat spinal cord or cerebral cortex. The dissociated cells are plated directly on poly‐L‐lysine‐coated cover slips and maintained in a modified myelination medium that supports both OL and neuron differentiation. The spinal cord derived OL progenitor cells develop quickly into myelin basic protein (MBP)+ mature OLs and start to myelinate axons around 17 days in vitro (DIV17). Myelination reaches its peak around six weeks (DIV40) and the typical nodes of Ranvier are revealed by paranodal proteins Caspr and juxaparanodal protein Kv1.2 immunoreactivity. Electron microscopy (EM) shows typical myelination cytoarchitecture and synaptic organization. In contrast, the cortical‐derived co‐culture requires triiodothyronine (T3) in the culture medium for myelination. Finally, either hypomyelination and/or demyelination can be induced by exposing proinflammatory cytokines or demyelinating agents to the co‐culture, suggesting the feasibility of this modified in vitro myelination model for myelin‐deficit investigation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here